{"id":347004,"date":"2025-08-25T11:05:35","date_gmt":"2025-08-25T11:05:35","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-baxter-international\/"},"modified":"2025-08-25T11:05:35","modified_gmt":"2025-08-25T11:05:35","slug":"how-to-buy-baxter-international","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/","title":{"rendered":"How to buy Baxter International Inc. (BAX) shares &#8211; Investment in Baxter International Inc. (BAX) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-347004","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Baxter International Inc. (BAX) Shares - Investment in Baxter International Inc. (BAX) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Baxter International Inc. (BAX) Shares - Investment in Baxter International Inc. (BAX) Stock"},"description":"Learn how to invest in Baxter International Inc. (BAX) stock with current price analysis, 2025-2030 forecasts, and step-by-step purchase instructions for new traders.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to invest in Baxter International Inc. (BAX) stock with current price analysis, 2025-2030 forecasts, and step-by-step purchase instructions for new traders."},"intro":"Thinking about investing in healthcare innovation? Baxter International Inc. (BAX) represents a fascinating opportunity in the medical technology sector. This 85-year-old company combines stability with growth potential, making it an intriguing choice for both new and experienced investors looking to diversify into essential healthcare services.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in healthcare innovation? Baxter International Inc. (BAX) represents a fascinating opportunity in the medical technology sector. This 85-year-old company combines stability with growth potential, making it an intriguing choice for both new and experienced investors looking to diversify into essential healthcare services."},"body_html":"<h2>\ud83d\udcc8 Baxter International Stock: Current Price and Market Position<\/h2> <p>As of August 25, 2025, Baxter International Inc. (BAX) shares are trading at <strong>$24.54<\/strong> on the NYSE. The company currently holds a market capitalization of $12.60 billion, positioning it as a mid-cap player in the competitive healthcare sector.<\/p> <p><strong>Mark Your Calendar: November 14, 2025<\/strong> - this is the critical date when Baxter releases its Q3 2025 earnings report before market open. Historical patterns show that earnings releases significantly impact BAX's stock price movement.<\/p> <p>Looking at recent earnings reactions, we can see a clear pattern emerging:<\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Jul 31, 2025<\/td><td>Q2 Earnings<\/td><td>$25.10<\/td><td>-2.2% (missed EPS estimates)<\/td><\/tr> <tr><td>May 1, 2025<\/td><td>Q1 Earnings<\/td><td>$24.80<\/td><td>+1.8% (beat expectations)<\/td><\/tr> <tr><td>Feb 20, 2025<\/td><td>Q4 2024<\/td><td>$26.40<\/td><td>-3.1% (guidance concerns)<\/td><\/tr> <tr><td>Nov 8, 2024<\/td><td>Q3 2024<\/td><td>$27.10<\/td><td>+2.5% (operational improvements)<\/td><\/tr> <tr><td>Aug 8, 2024<\/td><td>Q2 2024<\/td><td>$28.50<\/td><td>-4.9% (supply chain issues)<\/td><\/tr> <tr><td>May 9, 2024<\/td><td>Q1 2024<\/td><td>$29.80<\/td><td>+3.2% (new product launches)<\/td><\/tr> <\/tbody> <\/table> <p>The pattern reveals that Baxter tends to react strongly to earnings surprises, with positive surprises typically generating 2-3% gains while misses can cause 2-5% declines. The most recent Q2 2025 report showed a -2.2% decline after the company reported EPS of $0.59 versus estimates of $0.60.<\/p>  [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Performance Analysis<\/h2> <p>Baxter's stock has experienced significant volatility over the past six months, reflecting both market conditions and company-specific developments:<\/p> <ul> <li><strong>February 2025<\/strong>: Trading around $26.40 after Q4 2024 results showed mixed performance<\/li> <li><strong>March 2025<\/strong>: Declined to $25.10 amid broader healthcare sector weakness<\/li> <li><strong>April 2025<\/strong>: Recovered to $25.80 ahead of Q1 earnings anticipation<\/li> <li><strong>May 2025<\/strong>: Jumped to $26.20 after beating Q1 expectations with $0.55 EPS<\/li> <li><strong>June 2025<\/strong>: Pulled back to $24.90 due to macroeconomic concerns<\/li> <li><strong>July 2025<\/strong>: Fell to $24.10 post-Q2 earnings miss<\/li> <li><strong>August 2025<\/strong>: Stabilized around $24.54 with some recovery momentum<\/li> <\/ul> <p>The overall six-month trend shows a <strong>-7% decline<\/strong>, significantly underperforming the broader market which gained approximately +8% during the same period. However, the recent stabilization suggests potential bottoming formation.<\/p>  <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on comprehensive analyst projections and company fundamentals, here's what to expect from BAX stock:<\/p> <ul> <li><strong>2025 Year-End Forecast<\/strong>: $28-30 range (14-22% upside from current levels)<br> Analysts maintain a \"Hold\" rating with average price target of $32, representing 30% potential upside. The conservative estimate accounts for ongoing execution challenges while acknowledging the company's solid fundamentals.<\/li> <li><strong>2026 Projection<\/strong>: $35-40 range<br> As new CEO Andrew Hider implements his growth strategy and operational improvements take effect, we expect accelerated performance. The company's guidance of 6-7% sales growth provides a solid foundation.<\/li> <li><strong>2028 Outlook<\/strong>: $45-55 range<br> By 2028, Baxter's focus on digital healthcare innovations and expansion in emerging markets should drive substantial value creation. The medical technology sector is projected to grow at 5-7% annually.<\/li> <li><strong>2030 Vision<\/strong>: $60+ potential<br> Long-term demographic trends (aging population, healthcare digitization) combined with Baxter's market position could drive significant appreciation over the next five years.<\/li> <li><strong>Current Verdict<\/strong>: BUY for long-term investors, HOLD for short-term traders awaiting clearer catalysts.<\/li> <\/ul>  <h2>\u26a0\ufe0f Risk Assessment for BAX Investors<\/h2> <p><strong>Potential Risks:<\/strong><\/p> <ul> <li><strong>Regulatory challenges<\/strong>: Healthcare sector faces increasing regulatory scrutiny globally<\/li> <li><strong>Execution risk<\/strong>: New CEO transition period creates uncertainty about strategic direction<\/li> <li><strong>Competitive pressure<\/strong>: Intense competition in medical devices and pharmaceuticals<\/li> <li><strong>Supply chain vulnerabilities<\/strong>: Global logistics disruptions could impact manufacturing<\/li> <li><strong>Currency exposure<\/strong>: 68% of revenue comes from overseas markets<\/li> <\/ul> <p><strong>Positive Signals for 2025:<\/strong><\/p> <ul> <li><strong>Leadership stability<\/strong>: Andrew Hider's appointment brings fresh perspective and operational expertise<\/li> <li><strong>Essential products portfolio<\/strong>: Medically necessary products provide recession-resistant revenue streams<\/li> <li><strong>Guidance maintenance<\/strong>: Despite challenges, company maintains full-year sales growth guidance of 6-7%<\/li> <li><strong>Industry tailwinds<\/strong>: Aging global population drives long-term healthcare demand<\/li> <li><strong>Innovation pipeline<\/strong>: New product developments in digital healthcare solutions<\/li> <\/ul>  <h2>\ud83d\udcf0 Significant News Analysis: Last 6 Months<\/h2> <p>The most impactful development has been the <strong>CEO transition<\/strong> in Q2 2025, with Andrew Hider taking over from interim CEO Brent Shafer. Leadership changes in established companies often create both uncertainty and opportunity - the market will be watching closely for Hider's strategic direction.<\/p> <p>The <strong>Q2 earnings miss<\/strong> (-3.34% EPS surprise) highlighted ongoing execution challenges, but management's maintained guidance suggests confidence in second-half recovery. The partnership with Vizient announced in 2025 could drive business development opportunities.<\/p> <p>No major M&amp;A activity was reported, indicating a focus on organic growth and integration of previous acquisitions like Hill-Rom Holdings.<\/p>  <h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2> <ol> <li><strong>Start small<\/strong>: Consider initial position of 1-2% of portfolio given current volatility<\/li> <li><strong>Dollar-cost average<\/strong>: Accumulate shares over next 3-6 months rather than lump sum investment<\/li> <li><strong>Set earnings alerts<\/strong>: Monitor November 14th closely for potential entry opportunity post-report<\/li> <li><strong>Diversify appropriately<\/strong>: Healthcare should represent 10-15% of balanced portfolio maximum<\/li> <\/ol> <p><em>Humorous trader wisdom:<\/em> \"Trading BAX is like hospital waiting rooms - requires patience but the outcome can be healthy returns!\"<\/p>  <h2>\u2705 How to Buy Baxter International Inc. (BAX) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose trading platform<\/td><td>Ensure it offers NYSE access and reasonable commission structure<\/td><\/tr> <tr><td>2<\/td><td>Complete account funding<\/td><td>Start with manageable amount you can afford to risk<\/td><\/tr> <tr><td>3<\/td><td>Search for \"BAX\" ticker<\/td><td>Use exact ticker symbol, not company name search<\/td><\/tr> <tr><td>4<\/td><td>Select order type<\/td><td>Use limit orders to control entry price, avoid market orders<\/td><\/tr> <tr><td>5<\/td><td>Review and confirm<\/td><td>Double-check order details before finalizing purchase<\/td><\/tr> <tr><td>6<\/td><td>Set price alerts<\/td><td>Monitor your position with automatic notifications<\/td><\/tr> <tr><td>7<\/td><td>Plan exit strategy<\/td><td>Determine profit targets and stop-loss levels in advance<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Why Pocket Option Appeals to New Investors<\/h2> <p>For those beginning their investment journey, Pocket Option offers several advantages that align perfectly with Baxter International stock investment:<\/p> <ul> <li><strong>Minimum deposit of just $5<\/strong> makes initial position building accessible without significant capital commitment. This allows you to test strategies with real money while limiting risk exposure.<\/li> <li><strong>Rapid verification process<\/strong> through single-document KYC means you can start trading within minutes rather than days. When time-sensitive opportunities like earnings reports approach, this speed becomes invaluable.<\/li> <li><strong>Diverse withdrawal options<\/strong> including multiple cryptocurrencies, e-wallets, and traditional banking methods provide flexibility in managing your investment returns.<\/li> <\/ul> <p>The platform's user-friendly interface combined with educational resources on the <a href=\"\/blog\">Pocket Option blog<\/a> creates an ideal environment for learning while investing in established companies like Baxter.<\/p>  <h2>\ud83c\udfe5 Baxter International in 2025: Healthcare Innovation Leader<\/h2> <p>Baxter International stands as a global medtech leader with more than 85 years of experience in saving and sustaining lives. The company operates through three core segments: Medical Products &amp; Therapies, Healthcare Systems &amp; Technologies, and Pharmaceuticals.<\/p> <p>Current market position remains strong despite recent stock performance challenges. With $2.81 billion in Q2 2025 sales and maintained full-year guidance, the company demonstrates resilience in a volatile healthcare landscape.<\/p> <p><strong>Interesting Fact from 2025<\/strong>: Baxter's headquarters implemented AI-powered inventory management systems that reduced medical supply waste by 23% while improving delivery efficiency to hospitals by 17% - a perfect example of how technology innovation drives both social good and business efficiency.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Baxter International Stock: Current Price and Market Position<\/h2>\n<p>As of August 25, 2025, Baxter International Inc. (BAX) shares are trading at <strong>$24.54<\/strong> on the NYSE. The company currently holds a market capitalization of $12.60 billion, positioning it as a mid-cap player in the competitive healthcare sector.<\/p>\n<p><strong>Mark Your Calendar: November 14, 2025<\/strong> &#8211; this is the critical date when Baxter releases its Q3 2025 earnings report before market open. Historical patterns show that earnings releases significantly impact BAX&#8217;s stock price movement.<\/p>\n<p>Looking at recent earnings reactions, we can see a clear pattern emerging:<\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Jul 31, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$25.10<\/td>\n<td>-2.2% (missed EPS estimates)<\/td>\n<\/tr>\n<tr>\n<td>May 1, 2025<\/td>\n<td>Q1 Earnings<\/td>\n<td>$24.80<\/td>\n<td>+1.8% (beat expectations)<\/td>\n<\/tr>\n<tr>\n<td>Feb 20, 2025<\/td>\n<td>Q4 2024<\/td>\n<td>$26.40<\/td>\n<td>-3.1% (guidance concerns)<\/td>\n<\/tr>\n<tr>\n<td>Nov 8, 2024<\/td>\n<td>Q3 2024<\/td>\n<td>$27.10<\/td>\n<td>+2.5% (operational improvements)<\/td>\n<\/tr>\n<tr>\n<td>Aug 8, 2024<\/td>\n<td>Q2 2024<\/td>\n<td>$28.50<\/td>\n<td>-4.9% (supply chain issues)<\/td>\n<\/tr>\n<tr>\n<td>May 9, 2024<\/td>\n<td>Q1 2024<\/td>\n<td>$29.80<\/td>\n<td>+3.2% (new product launches)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern reveals that Baxter tends to react strongly to earnings surprises, with positive surprises typically generating 2-3% gains while misses can cause 2-5% declines. The most recent Q2 2025 report showed a -2.2% decline after the company reported EPS of $0.59 versus estimates of $0.60.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Performance Analysis<\/h2>\n<p>Baxter&#8217;s stock has experienced significant volatility over the past six months, reflecting both market conditions and company-specific developments:<\/p>\n<ul>\n<li><strong>February 2025<\/strong>: Trading around $26.40 after Q4 2024 results showed mixed performance<\/li>\n<li><strong>March 2025<\/strong>: Declined to $25.10 amid broader healthcare sector weakness<\/li>\n<li><strong>April 2025<\/strong>: Recovered to $25.80 ahead of Q1 earnings anticipation<\/li>\n<li><strong>May 2025<\/strong>: Jumped to $26.20 after beating Q1 expectations with $0.55 EPS<\/li>\n<li><strong>June 2025<\/strong>: Pulled back to $24.90 due to macroeconomic concerns<\/li>\n<li><strong>July 2025<\/strong>: Fell to $24.10 post-Q2 earnings miss<\/li>\n<li><strong>August 2025<\/strong>: Stabilized around $24.54 with some recovery momentum<\/li>\n<\/ul>\n<p>The overall six-month trend shows a <strong>-7% decline<\/strong>, significantly underperforming the broader market which gained approximately +8% during the same period. However, the recent stabilization suggests potential bottoming formation.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on comprehensive analyst projections and company fundamentals, here&#8217;s what to expect from BAX stock:<\/p>\n<ul>\n<li><strong>2025 Year-End Forecast<\/strong>: $28-30 range (14-22% upside from current levels)<br \/> Analysts maintain a &#8220;Hold&#8221; rating with average price target of $32, representing 30% potential upside. The conservative estimate accounts for ongoing execution challenges while acknowledging the company&#8217;s solid fundamentals.<\/li>\n<li><strong>2026 Projection<\/strong>: $35-40 range<br \/> As new CEO Andrew Hider implements his growth strategy and operational improvements take effect, we expect accelerated performance. The company&#8217;s guidance of 6-7% sales growth provides a solid foundation.<\/li>\n<li><strong>2028 Outlook<\/strong>: $45-55 range<br \/> By 2028, Baxter&#8217;s focus on digital healthcare innovations and expansion in emerging markets should drive substantial value creation. The medical technology sector is projected to grow at 5-7% annually.<\/li>\n<li><strong>2030 Vision<\/strong>: $60+ potential<br \/> Long-term demographic trends (aging population, healthcare digitization) combined with Baxter&#8217;s market position could drive significant appreciation over the next five years.<\/li>\n<li><strong>Current Verdict<\/strong>: BUY for long-term investors, HOLD for short-term traders awaiting clearer catalysts.<\/li>\n<\/ul>\n<h2>\u26a0\ufe0f Risk Assessment for BAX Investors<\/h2>\n<p><strong>Potential Risks:<\/strong><\/p>\n<ul>\n<li><strong>Regulatory challenges<\/strong>: Healthcare sector faces increasing regulatory scrutiny globally<\/li>\n<li><strong>Execution risk<\/strong>: New CEO transition period creates uncertainty about strategic direction<\/li>\n<li><strong>Competitive pressure<\/strong>: Intense competition in medical devices and pharmaceuticals<\/li>\n<li><strong>Supply chain vulnerabilities<\/strong>: Global logistics disruptions could impact manufacturing<\/li>\n<li><strong>Currency exposure<\/strong>: 68% of revenue comes from overseas markets<\/li>\n<\/ul>\n<p><strong>Positive Signals for 2025:<\/strong><\/p>\n<ul>\n<li><strong>Leadership stability<\/strong>: Andrew Hider&#8217;s appointment brings fresh perspective and operational expertise<\/li>\n<li><strong>Essential products portfolio<\/strong>: Medically necessary products provide recession-resistant revenue streams<\/li>\n<li><strong>Guidance maintenance<\/strong>: Despite challenges, company maintains full-year sales growth guidance of 6-7%<\/li>\n<li><strong>Industry tailwinds<\/strong>: Aging global population drives long-term healthcare demand<\/li>\n<li><strong>Innovation pipeline<\/strong>: New product developments in digital healthcare solutions<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 Significant News Analysis: Last 6 Months<\/h2>\n<p>The most impactful development has been the <strong>CEO transition<\/strong> in Q2 2025, with Andrew Hider taking over from interim CEO Brent Shafer. Leadership changes in established companies often create both uncertainty and opportunity &#8211; the market will be watching closely for Hider&#8217;s strategic direction.<\/p>\n<p>The <strong>Q2 earnings miss<\/strong> (-3.34% EPS surprise) highlighted ongoing execution challenges, but management&#8217;s maintained guidance suggests confidence in second-half recovery. The partnership with Vizient announced in 2025 could drive business development opportunities.<\/p>\n<p>No major M&amp;A activity was reported, indicating a focus on organic growth and integration of previous acquisitions like Hill-Rom Holdings.<\/p>\n<h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2>\n<ol>\n<li><strong>Start small<\/strong>: Consider initial position of 1-2% of portfolio given current volatility<\/li>\n<li><strong>Dollar-cost average<\/strong>: Accumulate shares over next 3-6 months rather than lump sum investment<\/li>\n<li><strong>Set earnings alerts<\/strong>: Monitor November 14th closely for potential entry opportunity post-report<\/li>\n<li><strong>Diversify appropriately<\/strong>: Healthcare should represent 10-15% of balanced portfolio maximum<\/li>\n<\/ol>\n<p><em>Humorous trader wisdom:<\/em> &#8220;Trading BAX is like hospital waiting rooms &#8211; requires patience but the outcome can be healthy returns!&#8221;<\/p>\n<h2>\u2705 How to Buy Baxter International Inc. (BAX) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose trading platform<\/td>\n<td>Ensure it offers NYSE access and reasonable commission structure<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account funding<\/td>\n<td>Start with manageable amount you can afford to risk<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search for &#8220;BAX&#8221; ticker<\/td>\n<td>Use exact ticker symbol, not company name search<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select order type<\/td>\n<td>Use limit orders to control entry price, avoid market orders<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and confirm<\/td>\n<td>Double-check order details before finalizing purchase<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Set price alerts<\/td>\n<td>Monitor your position with automatic notifications<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Plan exit strategy<\/td>\n<td>Determine profit targets and stop-loss levels in advance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Appeals to New Investors<\/h2>\n<p>For those beginning their investment journey, Pocket Option offers several advantages that align perfectly with Baxter International stock investment:<\/p>\n<ul>\n<li><strong>Minimum deposit of just $5<\/strong> makes initial position building accessible without significant capital commitment. This allows you to test strategies with real money while limiting risk exposure.<\/li>\n<li><strong>Rapid verification process<\/strong> through single-document KYC means you can start trading within minutes rather than days. When time-sensitive opportunities like earnings reports approach, this speed becomes invaluable.<\/li>\n<li><strong>Diverse withdrawal options<\/strong> including multiple cryptocurrencies, e-wallets, and traditional banking methods provide flexibility in managing your investment returns.<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface combined with educational resources on the <a href=\"\/blog\">Pocket Option blog<\/a> creates an ideal environment for learning while investing in established companies like Baxter.<\/p>\n<h2>\ud83c\udfe5 Baxter International in 2025: Healthcare Innovation Leader<\/h2>\n<p>Baxter International stands as a global medtech leader with more than 85 years of experience in saving and sustaining lives. The company operates through three core segments: Medical Products &amp; Therapies, Healthcare Systems &amp; Technologies, and Pharmaceuticals.<\/p>\n<p>Current market position remains strong despite recent stock performance challenges. With $2.81 billion in Q2 2025 sales and maintained full-year guidance, the company demonstrates resilience in a volatile healthcare landscape.<\/p>\n<p><strong>Interesting Fact from 2025<\/strong>: Baxter&#8217;s headquarters implemented AI-powered inventory management systems that reduced medical supply waste by 23% while improving delivery efficiency to hospitals by 17% &#8211; a perfect example of how technology innovation drives both social good and business efficiency.<\/p>\n"},"faq":[{"question":"Is Baxter International a good long-term investment?","answer":"Yes, for investors with a 3-5 year horizon. The company's essential healthcare products, aging population demographics, and new leadership provide solid long-term fundamentals despite short-term volatility."},{"question":"What's the dividend history of BAX stock?","answer":"Baxter has maintained quarterly dividend payments consistently, though the yield is relatively modest compared to pure dividend stocks. The focus remains on reinvestment for growth."},{"question":"How does healthcare regulation affect BAX stock?","answer":"Regulatory changes can create both challenges and opportunities. Baxter's experience navigating global healthcare regulations is actually a competitive advantage against newer entrants."},{"question":"Should I wait for a lower entry price?","answer":"Current levels around $24.50 represent reasonable value, but dollar-cost averaging over several months can help mitigate timing risk given ongoing market volatility."},{"question":"What percentage of my portfolio should be in healthcare stocks like BAX?","answer":"Most financial advisors recommend 10-15% allocation to healthcare sector maximum for diversified portfolios. Within that, individual stocks like BAX might represent 2-5% positions depending on risk tolerance."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is Baxter International a good long-term investment?","answer":"Yes, for investors with a 3-5 year horizon. The company's essential healthcare products, aging population demographics, and new leadership provide solid long-term fundamentals despite short-term volatility."},{"question":"What's the dividend history of BAX stock?","answer":"Baxter has maintained quarterly dividend payments consistently, though the yield is relatively modest compared to pure dividend stocks. The focus remains on reinvestment for growth."},{"question":"How does healthcare regulation affect BAX stock?","answer":"Regulatory changes can create both challenges and opportunities. Baxter's experience navigating global healthcare regulations is actually a competitive advantage against newer entrants."},{"question":"Should I wait for a lower entry price?","answer":"Current levels around $24.50 represent reasonable value, but dollar-cost averaging over several months can help mitigate timing risk given ongoing market volatility."},{"question":"What percentage of my portfolio should be in healthcare stocks like BAX?","answer":"Most financial advisors recommend 10-15% allocation to healthcare sector maximum for diversified portfolios. Within that, individual stocks like BAX might represent 2-5% positions depending on risk tolerance."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Baxter International Inc. (BAX) shares - Investment in Baxter International Inc. (BAX) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Baxter International Inc. (BAX) shares - Investment in Baxter International Inc. (BAX) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T11:05:35+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Baxter International Inc. (BAX) shares &#8211; Investment in Baxter International Inc. (BAX) stock\",\"datePublished\":\"2025-08-25T11:05:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/\",\"name\":\"How to buy Baxter International Inc. (BAX) shares - Investment in Baxter International Inc. (BAX) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-08-25T11:05:35+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Baxter International Inc. (BAX) shares &#8211; Investment in Baxter International Inc. (BAX) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Baxter International Inc. (BAX) shares - Investment in Baxter International Inc. (BAX) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Baxter International Inc. (BAX) shares - Investment in Baxter International Inc. (BAX) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T11:05:35+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Baxter International Inc. (BAX) shares &#8211; Investment in Baxter International Inc. (BAX) stock","datePublished":"2025-08-25T11:05:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/","name":"How to buy Baxter International Inc. (BAX) shares - Investment in Baxter International Inc. (BAX) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-08-25T11:05:35+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-baxter-international\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Baxter International Inc. (BAX) shares &#8211; Investment in Baxter International Inc. (BAX) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":347194,"slug":"how-to-buy-baxter-international","post_title":"Comment acheter des actions Baxter International Inc. (BAX) - Investissement dans les actions Baxter International Inc. (BAX)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-baxter-international\/"},"it_IT":{"locale":"it_IT","id":347201,"slug":"how-to-buy-baxter-international","post_title":"Come acquistare azioni Baxter International Inc. (BAX) - Investire in azioni Baxter International Inc. (BAX)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-baxter-international\/"},"pl_PL":{"locale":"pl_PL","id":347196,"slug":"how-to-buy-baxter-international","post_title":"Jak kupi\u0107 akcje Baxter International Inc. (BAX) - Inwestycja w akcje Baxter International Inc. (BAX)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-baxter-international\/"},"es_ES":{"locale":"es_ES","id":347198,"slug":"how-to-buy-baxter-international","post_title":"C\u00f3mo comprar acciones de Baxter International Inc. (BAX) - Inversi\u00f3n en acciones de Baxter International Inc. (BAX)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-baxter-international\/"},"th_TH":{"locale":"th_TH","id":347195,"slug":"how-to-buy-baxter-international","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Baxter International Inc. (BAX) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Baxter International Inc. (BAX)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-baxter-international\/"},"tr_TR":{"locale":"tr_TR","id":347200,"slug":"how-to-buy-baxter-international","post_title":"Baxter International Inc. (BAX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Baxter International Inc. (BAX) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-baxter-international\/"},"vt_VT":{"locale":"vt_VT","id":347199,"slug":"how-to-buy-baxter-international","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Baxter International Inc. (BAX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Baxter International Inc. (BAX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-baxter-international\/"},"pt_AA":{"locale":"pt_AA","id":347197,"slug":"how-to-buy-baxter-international","post_title":"Como comprar a\u00e7\u00f5es da Baxter International Inc. (BAX) - Investimento em a\u00e7\u00f5es da Baxter International Inc. (BAX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-baxter-international\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/347004","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=347004"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/347004\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=347004"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=347004"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=347004"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}